Norgestrel tablets are indicated for use by females of reproductive potential to prevent pregnancy. 

Prevention of Pregnancy

Norgestrel Tablets must be taken exactly as directed to achieve maximum contraceptive effectiveness. Every day, the woman should take one tablet at the same time. The administration is continuous, with no breaks between pill packs.

The following adverse reactions were reported with the use of norgestrel-

• Delayed follicular atresia/ovarian cysts
• Menstrual irregularity, changes in menstrual flow; breakthrough bleeding/spotting; amenorrhea, prolonged bleeding 
• Headache
• Dizziness
• Nausea
• Increased appetite
• Abdominal pain, cramps and bloating
• Fatigue
• Vaginal discharge
• Dysmenorrhea 
• Nervousness
• Backache
• Breast discomfort
• Acne

Ovarian Cyst	Menstrual Disorder	Headache
Dysmenorrhea	Nervousness	Acne

• Because women with migraine are at an increased risk of stroke, the onset or exacerbation of migraine, or the development of headache with a new pattern that is recurrent, persistent, or severe, necessitates an evaluation of the cause.
• Hepatic enzyme-inducing drugs such as phenytoin, carbamazepine, barbiturates, rifampin, efavirenz, bosentan, and herbal preparations containing St. John's Wort reduce the efficacy of progestin-only pills (hypericum perforatum). This could result in an unintended pregnancy or unexpected bleeding.
• Within 4 hours of taking a pill, diarrhea and/or vomiting may reduce hormone absorption. During the next 48 hours, women should use a nonhormonal birth control method (such as a condom or spermicide).
• Norgestrel Tablets are contraindicated for use in pregnant women because there is no need for pregnancy prevention in a woman who is already pregnant 
• Breast milk contains trace amounts of progestin, which results in steroid levels in infant plasma. There have been no reports of negative effects on breastfeeding performance or infant health.
• The limited data available do not show a significant delay in the return of normal ovulation and fertility after discontinuation of progestin-only oral contraceptives.

• Norgestrel Tablets should be taken at the same time every day, including during periods of bleeding.
• For the next 48 hours, she should use a nonhormonal backup method of contraception (such as condoms or spermicides) whenever Norgestrel Tablets are taken 3 or more hours late, or if she has vomiting or diarrhea within 4 hours of taking the pill.
• Changes in their normal menstrual bleeding pattern may be associated with the use of Norgestrel Tablets. Women who have missed two periods (or who have missed a single period but have missed Norgestrel doses) or who suspect they may be pregnant should take a pregnancy test.
• She should inform her healthcare provider if she develops repeated vaginal postcoital bleeding, prolonged episodes of bleeding, amenorrhea or development of severe abdominal pain.
• Norgestrel Tablets do not provide protection against HIV or other sexually transmitted infections (STIs).